[FOR RELEASE September 24, 2019 China Biologic Forms Special Committee to Review “Going Private” Proposal BEIJING, China – September 24, 2019 – The Special Committee is composed of Mr. Sean Shao, Dr. Yungang Lu and Mr. Qi Ning, who are independent directors of the Company and are unaffiliated with th]
[FOR RELEASE September 24, 2019 China Biologic Forms Special Committee to Review “Going Private” Proposal BEIJING, China – September 24, 2019 – The Special Committee is composed of Mr. Sean Shao, Dr. Yungang Lu and Mr. Qi Ning, who are independent directors of the Company and are unaffiliated with th]
[CONSORTIUM AGREEMENT Agreement Centurium 普华和顺集团公司 PWM CITIC Parfield Hillhouse Temasek Initial Consortium Members Party Parties This CONSORTIUM AGREEMENT (this “ Transaction Company Buyer Consortium WHEREAS, the Parties propose to undertake an acquisition transaction (the “ Holdco Merger Sub Closing]
[CONSORTIUM AGREEMENT Agreement Centurium 普华和顺集团公司 PWM CITIC Parfield Hillhouse Temasek Initial Consortium Members Party Parties This CONSORTIUM AGREEMENT (this “ Transaction Company Buyer Consortium WHEREAS, the Parties propose to undertake an acquisition transaction (the “ Holdco Merger Sub Closing]
[FOR RELEASE September 18, 2019 China Biologic Announces Receipt of Preliminary Non-Binding “Going Private” Proposal BEIJING, China – September 18, 2019 – Annex A A copy of the proposal letter is attached as In connection with the submission of the proposal letter by the Buyer Group and the Transacti]
[FOR RELEASE September 18, 2019 China Biologic Announces Receipt of Preliminary Non-Binding “Going Private” Proposal BEIJING, China – September 18, 2019 – Annex A A copy of the proposal letter is attached as In connection with the submission of the proposal letter by the Buyer Group and the Transacti]
[FOR RELEASE August 5, 2019 China Biologic Reports Financial Results for the Second Quarter of 2019 —2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms — —1H19 Total Sales Up 14.0% YoY]
[FOR RELEASE August 5, 2019 China Biologic Reports Financial Results for the Second Quarter of 2019 —2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms — —1H19 Total Sales Up 14.0% YoY]
